miR-495 inhibits proliferation, migration, and invasion and induces apoptosis via inhibiting PBX3 in melanoma cells. 2018

Guangxiong Chen, and Yijie Xie
Department of Dermatology, Yinzhou People's Hospital, Ningbo City, Zhejiang Province, China.

BACKGROUND Amounting evidence indicate that miRNAs play an important role in the development of various cancers. MiR-495 is a potential tumor suppressor in cancers, however its role in melanoma is still elusive. The study aimed to investigate the role of miR-495 and the underlying mechanisms in melanoma cells. METHODS The levels of miR-495 in melanoma tissues and cell lines were measured by quantitative real-time polymerase chain reaction. Mimics of miR-495 was transfected into human melanoma cells A375 and MeWo. Cell viability of miR-495-transfected cells was assayed by MTT assay. Cell migration and invasion of miR-495 transfected cells were measured by wound healing assay and transwell assay, respectively. Nucleosome enzyme-linked immunosorbent assay was performed to measure the apoptosis induced by overexpression of miR-495. Luciferase reporter assays were performed to verify the interaction between miR-495 and its target PBX3. RESULTS It was found that the expression levels of miR-495 were down-regulated in melanoma tissues and cells. Moreover, overexpression of miR-495 inhibited melanoma cell proliferation, migration and invasion in vitro. PBX3 was identified as a target for inhibition by miR-495 and was confirmed by luciferase assay, quantitative real-time polymerase chain reaction and western blot. We also indicated that silencing of PBX3 also repressed melanoma cell proliferation, migration and invasion in vitro. CONCLUSIONS In summary, our findings demonstrated that miR-495 functions as a tumor suppressor in human melanoma via directly targeting PBX3.

UI MeSH Term Description Entries

Related Publications

Guangxiong Chen, and Yijie Xie
March 2019, Pathology, research and practice,
Guangxiong Chen, and Yijie Xie
December 2022, Cancer biotherapy & radiopharmaceuticals,
Guangxiong Chen, and Yijie Xie
October 2017, Experimental and therapeutic medicine,
Guangxiong Chen, and Yijie Xie
November 2019, Journal of cellular physiology,
Guangxiong Chen, and Yijie Xie
November 2019, European review for medical and pharmacological sciences,
Guangxiong Chen, and Yijie Xie
September 2019, Acta biochimica et biophysica Sinica,
Guangxiong Chen, and Yijie Xie
February 2024, Experimental and therapeutic medicine,
Guangxiong Chen, and Yijie Xie
November 2018, Journal of cellular biochemistry,
Guangxiong Chen, and Yijie Xie
January 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology,
Copied contents to your clipboard!